Akanda (NASDAQ:AKAN) Cut to “Strong Sell” at Wall Street Zen

Wall Street Zen downgraded shares of Akanda (NASDAQ:AKAN) from a sell rating to a strong sell rating in a research report sent to investors on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Akanda in a research report on Thursday, August 13th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Akanda Trading Up 4.6%

Akanda stock opened at $4.07 on Friday. Akanda has a 1-year low of $2.30 and a 1-year high of $209.02. The firm has a 50 day simple moving average of $7.98 and a 200 day simple moving average of $10.14.

Akanda (NASDAQ:AKAN) last issued its earnings results on Tuesday, June 9th. The company reported ($317.90) earnings per share (EPS) for the quarter.

Akanda Company Profile

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.